APA (7th ed.) Citation

Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., . . . Schoepp, D. D. (2007). Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial. Nature medicine, 13(9), 1102-1107. https://doi.org/10.1038/nm1632

Chicago Style (17th ed.) Citation

Patil, Sandeep T., et al. "Activation of MGlu2/3 Receptors as a New Approach to Treat Schizophrenia: A Randomized Phase 2 Clinical Trial." Nature Medicine 13, no. 9 (2007): 1102-1107. https://doi.org/10.1038/nm1632.

MLA (9th ed.) Citation

Patil, Sandeep T., et al. "Activation of MGlu2/3 Receptors as a New Approach to Treat Schizophrenia: A Randomized Phase 2 Clinical Trial." Nature Medicine, vol. 13, no. 9, 2007, pp. 1102-1107, https://doi.org/10.1038/nm1632.